Seach Medical Group Ltd (SEMG) - Total Assets
Based on the latest financial reports, Seach Medical Group Ltd (SEMG) holds total assets worth ILA148.91 Million ILA (≈ $399.23K USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Seach Medical Group Ltd (SEMG) net assets for net asset value and shareholders' equity analysis.
Seach Medical Group Ltd - Total Assets Trend (2015–2024)
This chart illustrates how Seach Medical Group Ltd's total assets have evolved over time, based on quarterly financial data.
Seach Medical Group Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Seach Medical Group Ltd's total assets of ILA148.91 Million consist of 63.4% current assets and 36.6% non-current assets.
| Asset Category | Amount (ILA) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 12.2% |
| Accounts Receivable | ILA25.37 Million | 17.3% |
| Inventory | ILA38.87 Million | 26.4% |
| Property, Plant & Equipment | ILA0.00 | 0.0% |
| Intangible Assets | ILA0.00 | 0.0% |
| Goodwill | ILA22.36 Million | 15.2% |
Asset Composition Trend (2015–2024)
This chart illustrates how Seach Medical Group Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Seach Medical Group Ltd market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Seach Medical Group Ltd's current assets represent 63.4% of total assets in 2024, a decrease from 89.9% in 2015.
- Cash Position: Cash and equivalents constituted 12.2% of total assets in 2024, down from 31.2% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 15.0% of total assets, an increase from 0.0% in 2015.
- Asset Diversification: The largest asset category is inventory at 26.4% of total assets.
Seach Medical Group Ltd Competitors by Total Assets
Key competitors of Seach Medical Group Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Zhejiang Huahai Pharmaceutical Co Ltd
SHG:600521
|
China | CN¥21.15 Billion |
|
Emcure Pharmaceuticals Ltd
NSE:EMCURE
|
India | Rs93.93 Billion |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
|
China | CN¥5.17 Billion |
|
Ningbo Menovo Pharm Co Ltd
SHG:603538
|
China | CN¥4.75 Billion |
|
GALDERMA GROUP AG
NYSE:GALDY
|
USA | $13.39 Billion |
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
|
Sweden | Skr67.43 Billion |
|
Changzhou Qianhong Biopharma Co Ltd
SHE:002550
|
China | CN¥3.02 Billion |
Seach Medical Group Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.41 | 3.28 | 6.59 |
| Quick Ratio | 1.94 | 1.95 | 4.59 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ILA70.40 Million | ILA57.64 Million | ILA55.33 Million |
Seach Medical Group Ltd - Advanced Valuation Insights
This section examines the relationship between Seach Medical Group Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.13 |
| Asset Growth Rate (YoY) | 12.3% |
| Total Assets | ILA147.00 Million |
| Market Capitalization | $19.06 Million USD |
Valuation Analysis
Below Book Valuation: The market values Seach Medical Group Ltd's assets below their book value (0.13x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Seach Medical Group Ltd's assets grew by 12.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Seach Medical Group Ltd (2015–2024)
The table below shows the annual total assets of Seach Medical Group Ltd from 2015 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ILA147.00 Million ≈ $394.12K |
+12.31% |
| 2023-12-31 | ILA130.90 Million ≈ $350.93K |
-19.16% |
| 2022-12-31 | ILA161.93 Million ≈ $434.12K |
+26.08% |
| 2021-12-31 | ILA128.43 Million ≈ $344.32K |
+38.14% |
| 2020-12-31 | ILA92.97 Million ≈ $249.26K |
+38.50% |
| 2019-12-31 | ILA67.13 Million ≈ $179.97K |
+100.30% |
| 2018-12-31 | ILA33.51 Million ≈ $89.85K |
-6.49% |
| 2017-12-31 | ILA35.84 Million ≈ $96.08K |
+1541.73% |
| 2016-12-31 | ILA2.18 Million ≈ $5.85K |
-28.40% |
| 2015-12-31 | ILA3.05 Million ≈ $8.17K |
-- |
About Seach Medical Group Ltd
Seach Medical Group Ltd manufactures and sells medicinal cannabis products worldwide. The company offers cannabis oil and medical cannabis inflorescence products. Seach Medical Group Ltd was founded in 2002 and is based in Ramat Gan, Israel.